Anemia, Cancer, and Aging

Cancer Control

Volumn 10, Issue 6, 2003, Pages 478-486

  Balducci, Lodovico ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; CYTOKINE; ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

ABSORPTION; AGING; ANEMIA; CANCER; CANCER INCIDENCE; COMORBIDITY; CYANOCOBALAMIN DEFICIENCY; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY; REVIEW;

EID: 0344305707     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480301000606     Document Type: Review

References (79)

1. Day JC, Current Population Reports. Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050. US Bureau of the Census. Washington, DC: US Government Printing Office; 1996:5-1130. Available at: http://www.census.gov/ prod/1/pop/p25-1130/p251130a.pdf. Accessed August 12, 2003.
2. La Vecchia C, Lucchini F, Negri E, et al. Cancer mortality in the elderly, 1960-1998: a worldwide approach. Oncol Spectr. 2001;2: 386-394.
3. Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol. 2000;35:181-200.
4. Balducci L, Hardy CL. Anemia of aging: a model of erythropoiesis in cancer patients. Cancer Control. 1998;5(suppl 1):17-21.
5. Anía BJ, Suman VJ, Fairbanks VF, et al. Incidence of anemia in older people: an epidemiologic study in a well defined population. J Am Geriatr Soc. 1997;45:825-831.
6. Pierelli L, Perillo A, Greggi S, et al. Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison. J Clin Oncol. 1999;17:1288-1295.
7. Ratain MJ, Schilsky RL, Choi KE, et al. Adaptive control of etoposide administration: impact of interpatient pharmacodynamic variability. Clin Pharmacol Ther. 1989;45:226-233.
8. Silber JH, Fridman M, Di Paola RS, et al. First-cycle blood counts and subsequent neutropenia, dose reduction or delay in early stage breast cancer therapy. J Clin Oncol. 1998;16:2392-2400.
9. Extermann M, Chen H, Cantor AB, et al. Predictors of toxicity from chemotherapy in older patients: a prospective pilot study. Proc Annu Meet Am Soc Clin Oncol. 2000;19:2430. Abstract.
10. Schrijvers D, Highley M, De Bruyn E, et al. Role of red blood cells in pharmacokinetics of chemotherapeutic agents. Anticancer Drugs. 1999;10:147-153.
11. Spivak JL, Barnes DC, Fuchs E, et al. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA. 1989;261:3104-3107.
12. Gabrilove J. Overview: erythropoiesis, anemia, and the impact of erythropoietin. Semin Hematol. 2000;37(suppl 6):1-3.
13. Cleeland CS, Demetri GD, Glaspy J, et al. Identifying hemoglobin levels for optimal quality of life: results of an incremental analysis. Proc Annu Meet Am Soc Clin Oncol. 1999;18:2215. Abstract.
14. Gabrilove JL, Cleeland CS, Livingstone RB, et al. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol. 2001;19:2875-2882.
15. Littlewood TJ, Bajetta E, Nortier JW, et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2001;19:2865-2874.
16. Kulier A, Gombotz H. Perioperative anemia. Anaesthetist. 2001;50:73-86.
17. Carson JL, Poses RM, Spence RK, et al. Severity of anemia and operative mortality and morbidity. Lancet. 1998;1:727-729.
18. Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med. 1993;21:860-866.
19. Chaves PH, Volpato S, Fried L. Challenging the World Health Organization criteria for anemia in older women. J Am Geriatr Soc. 2001;49(suppl 3):10.
20. Chaves PH, Ashar B, Guralnik JM, et al. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women: should the criteria currently used to define anemia in older people be reevaluated? J Am Geriatr Soc. 2002;50:1257-1264.
21. Glaspy J, Bukowski R, Steinberg D, et al. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice: Procrit Study Group. J Clin Oncol. 1997;15:1218-1234.
22. Demetri GD, Kris M, Wade J, et al. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol. 1998;16: 3412-3425.
23. Smith DL. Anemia in the elderly. Am Fam Physician. 2000; 62:1565-1572.
24. Anía BJ, Suman VJ, Fairbanks VF, et al. Prevalence of anemia in medical practice: community versus referral patients. Mayo Clin Proc. 1994;69:730-735.
25. Inelmen EM, Alessio MD, Gatto MRA, et al. Descriptive analysis of the prevalence of anemia in a randomly selected sample of elderly people at home: some results of an Italian multicentric study. Aging. 1994;6:81-89.
26. Mansouri A, Lipschitz DA. Anemia in the elderly patient. Anemia. 1992;76:619-630.
27. Quaglino D, Ginaldi L, Furia N, et al. The effect of age on hemostasis. Aging (Milano). 1996;8:1-12.
28. Tran KH, Udden MM, Taffet GE, et al. Erythropoietin regulation of hematopoiesis is preserved in healthy elderly people. Clin Res. 1993;41:116a.
29. Zauber NP, Zauber AG. Hematologic data of healthy very old people. JAMA. 1987;257:2181-2184.
30. Duthie E. Physiology of aging: relevance to symptom perceptions and treatment tolerance. In: Balducci L, Lyman GH, Ershler WB. Comprehensive Geriatric Oncology. Amsterdam: Harwood Academic Publishers; 1998.
31. Balducci L, Hardy CL, Lyman GH. Hematopoietic growth factors in the older cancer patient. Curr Opin Hematol. 2001;8:170-187.
32. Cohen HJ, Piper CS, Harris T. Markers of inflammation and coagulation predict decline in function and mortality in community dwelling elderly. J Am Geriatr Soc. 2001;S1:A3.
33. Hamerman D, Berman JW, Albers GW, et al. Emerging evidence for inflammation in conditions frequently affecting older adults: report of a symposium. J Am Geriatr Soc. 1999;47:1016-1025.
34. Ershler WB. Biological interactions of aging and anemia: a focus on cytokines. J Am Geriatr Soc. 2003;51(suppl):8-21.
35. Paquette RL. Diagnosis and management of aplastic anemia and myelodysplastic syndrome. Oncology (Huntington). 2002;16 (suppl 10):153-161.
36. Ludwig H. Anemia and hematological malignancies: what are the treatment options? Semin Oncol. 2002;29(suppl 8):45-54.
37. Joosten E, Pelemans W, Hiele M, et al. Prevalence and causes of anaemia in a geriatric hospitalized population. Gerontology. 1992;38:111-117.
38. Anderson S, Brenner BM. Effects of aging on the renal glomerulus. Am J Med. 1986;80:435-442.
39. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461-470.
40. Krantz SB. Pathogenesis and treatment of the anemia of chronic disease. Am J Med Sci. 1994;307:353-359.
41. Chiari MM, Bagnoli R, De Luca P, et al. Influence of acute inflammation on iron and nutritional status indexes in older inpatients. J Am Geriatr Soc. 1995;43:767-771.
42. Murphy PT, Hutchinson RM. Identification and treatment of anaemia in older patients. Drugs Aging. 1994;4:113-127.
43. Abramson SD, Abramson N. "Common" uncommon anemias. Am Fam Physician. 1999;59:851-858.
44. Walsh JR. Hematologic problems. In: Cassel CK, Cohen HJ, Larson EB, eds. Geriatric Medicine. 3rd ed. New York, NY: Springer; 1997.
45. Daly MP. Anemia in the elderly. Am Fam Physician. 1989; 39:129-136.
46. Nafziger J, Pailla K, Luciani L, et al. Decreased erythropoietin responsiveness to iron deficiency anemia in the elderly. Am J Hematol. 1993;43:172-176.
47. Kario K, Matsuo T, Kodoma K, et al. Reduced erythropoietin secretion in senile anemia. Am J Hematol. 1992;41:252-257.
48. Carpenter MA, Kendall RG, O'Brien AE, et al. Reduced erythropoietin response to anaemia in elderly patients with normocytic anaemia. Eur J Haematol. 1992;49:119-121.
49. Tong EM, Nissenson AR. Erythropoietin and anemia. Semin Nephrol. 2001;21:190-203.
50. Chronic Kidney Disease. In: Healthy People 2010. Vol 1. Objectives for Improving Health. Part A: Focus Areas 1-14. US Dept of Health and Human Services; 2000.
51. Besarab A, Flaharty KK, Erslev AJ, et al. Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: the case for subcutaneous administration. J Am Soc Nephrol. 1992;2:1405-1416.
52. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med. 1996;156:1097-1100.
53. Sumner AE, Chin MM, Abrahm JL, et al. Elevated methyl-malonic acid and total homocysteine levels show high prevalence of vitamin B12 deficiency after gastric surgery. Ann Intern Med. 1996;124:469-476.
54. Norman EJ, Morrison JA. Screening elderly populations for cobalamin (vitamin B12) deficiency using the urinary methylmalonic acid assay by gas chromatography mass spectrometry. Am J Med. 1993;94:489-494.
55. Goodnough LT, Price TH, Parvin CA. The endogenous erythropoietin response and the erythropoietic response to blood loss anemia: the effects of age and gender. J Lab Clin Med. 1995;126:57-64.
56. Powers JS, Krantz SB, Collins JC, et al. Erythropoietin response to anemia as a function of age. J Am Geriatr Soc. 1991;39:30-32.
57. Fried LP, Storer DJ, King DE, et al. Diagnosis of illness presentation in the elderly. J Am Geriatr Soc. 1991;39:117-123.
58. Luciani A, Balducci L. Age and multiple primary malignancies. Semin Oncol. In press.
59. Ahluwalia N, Lammi-Keefe CJ, Bendel RB, et al. Iron deficiency and anemia of chronic disease in elderly women: a discriminate-analysis approach for differentiation. Am J Clin Nutr. 1995;61:590-596.
60. Izaks GJ, Westendorp RG, Knook DL. The definition of anemia in older persons. JAMA. 1999;281:1714-1717.
61. Kikuchi M, Inagaki T, Shinagawa N. Five-year survival of older people with anemia: variation with hemoglobin concentration. J Am Geriatr Soc. 2001;49:1226-1228.
62. Gagnon DR, Zhang TJ, Brand FN, et al. Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up. Am Heart J. 1994;127:674-682.
63. Rieger PT. Assessment and epidemiologic issues related to fatigue. Cancer. 2001;96(suppl):1733-1736.
64. Respini D, Jacobsen PB, Thors C, et al. The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol. 2003;47:273-279.
65. Liao S, Ferrell BA. Fatigue in an older population. J Am Geriatr Soc. 2000;48:426-430.
66. Gutstein HB. The biologic basis of fatigue. Cancer. 2001;92 (suppl):1678-1683.
67. Metivier F, Marchais SJ, Guerin AP, et al. Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant. 2000;15(suppl 3):14-18.
68. Levin A, Singer J, Thompson CR, et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996;27:347-354.
69. Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737-1744.
70. Wu WC, Rathore SS, Wang Y, et al. Blood transfusions in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345: 1230-1236.
71. Beard CM, Kokmen E, O'Brien PC, et al. Risk of Alzheimer's disease among elderly patients with anemia: population-based investigations in Olmsted County, Minnesota. Ann Epidemiol. 1997;7:219-224.
72. Cella D. The Functional Assessment of Cancer Therapy - Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol. 1997;34(suppl 2):13-19.
73. Katz IR, Beaston-Wimmer P, Parmelee P, et al. Failure to thrive in the elderly: exploration of the concept and delineation of psychiatric components. J Geriatr Psychiatry Neurol. 1993;6:161-169.
74. Yellen SB, Cella DF, Webster K, et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13:63-74.
75. Nissenson AR. Epoetin and cognitive function. Am J Kidney Dis. 1992;20(suppl 1):21-24.
76. Pickett JL, Theberge DC, Brown WS, et al. Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis. 1999;33:1122-1130.
77. Marcantonio ER, Flacker JM, Michaels M, et al. Delirium is independently associated with poor functional recovery after hip fracture. J Am Geriatr Soc. 2000;48:618-624.
78. Melton LJ III, Khosla S, Crowson CS, et al. Epidemiology of sarcopenia. J Am Geriatr Soc. 2000;48:625-630.
79. Aslani A, Smith RC, Allen BJ. The predictive value of body proteins for chemotherapy induced toxicity. Cancer. 2000;88:796-803.